Capecitabine (UK) – Patient Guide

Capecitabine is an anti-cancer medicine used to treat certain types of cancer. This page explains, in clear terms, what capecitabine is, how it works, how it is taken, what to expect, and key safety information. It is written for use by people in the United Kingdom and includes practical guidance to help you use the medicine safely.

Important: Cancer medicines can affect different people in different ways. Always follow the instructions given by your oncology team and the guidance on your medicine label.

1. Basic product information

2. How capecitabine works (mechanism of action)

Capecitabine is a “prodrug” of 5-fluorouracil (5-FU). A prodrug is a medicine that is converted in the body into its active form. After you take capecitabine, your body converts it into 5-FU mainly in tissues including those related to tumour growth.

The active 5-FU affects cancer cells by interfering with DNA and RNA production, which helps stop rapidly dividing cells. Specifically, it works by:

• Inhibiting thymidylate synthase, an enzyme needed for making DNA building blocks.
• Disrupting RNA and protein production in ways that interfere with cancer cell growth.

Because many cancer cells divide quickly, they are more likely than normal cells to be affected by these changes.

3. Pharmacokinetics – what the body does to capecitabine

“Pharmacokinetics” describes how the body absorbs, processes, and eliminates a medicine. The exact values may vary between individuals, but the overall pattern is consistent:

• Absorption: Capecitabine is taken by mouth and absorbed from the gastrointestinal tract.
• Conversion to active drug: It is converted in a stepwise process to 5-FU and related metabolites.
• Distribution: The active metabolites circulate through the bloodstream and reach tissues.
• Metabolism and clearance: The body breaks down capecitabine and its metabolites, which are mainly eliminated through the kidneys (urine).

For many patients, kidney function is an important factor. If you have reduced kidney function, your oncology team may adjust the dose and monitor you more closely.

4. Typical uses in the UK

Capecitabine is used to treat several cancers, often as an oral alternative to 5-FU–based chemotherapy. It may be used:

• Adjuvantly (after surgery) to help reduce the risk of cancer coming back
• As treatment for advanced or metastatic disease (when cancer has spread)
• In combination with other medicines in some regimens

Common cancer types where capecitabine may be used (depending on clinical situation) include:

• Breast cancer (for certain stages and treatment settings)
• Colorectal cancer (including rectal cancer in some settings)
• Gastro-oesophageal (stomach/upper digestive tract) cancers in certain regimens
• Other GI-associated cancers depending on treatment protocol

Your clinician will determine the exact approach based on the tumour type, stage, prior treatments, and overall health.

5. Timing and how to take capecitabine

Many capecitabine regimens are given in cycles. A common schedule is:

• Twice daily dosing (morning and evening) on specified days, followed by a rest period
• Cycles repeat according to the protocol your oncology team uses

Key practical points:

• Swallow tablets whole with water. Do not crush or chew unless your clinical team instructs otherwise.
• Try to keep dosing times consistent. This helps maintain steady medicine exposure.
• If you miss a dose: Follow your oncology team’s instructions. In general, do not take extra doses to “catch up” unless told to do so. Contact your clinic or pharmacist for advice.
• Do not stop or change your regimen without discussing it with your cancer team.

6. Food interactions (what to eat and when)

Capecitabine can be taken with or without food depending on your local guidance and regimen. However, many clinicians advise that it is taken after food to reduce gastrointestinal discomfort and improve tolerability.

A common approach is:

• Take the morning dose after breakfast
• Take the evening dose after your evening meal

Why this matters: Food may influence how much of the medicine is absorbed. Consistency helps your treatment stay on schedule.

If you have swallowing difficulties, severe nausea, or you’re unsure how to align doses with eating, ask your oncology team or pharmacist. They can help you plan timing for your particular routine.

7. Alcohol and medicine interactions

Alcohol: There is no single universal “safe amount,” but alcohol can worsen side effects such as:

• nausea and vomiting
• diarrhoea
• fatigue
• dehydration
• liver stress (particularly if you already have liver involvement or abnormal blood tests)

It’s generally advisable to limit or avoid alcohol during treatment, especially if you experience side effects. If you choose to drink, discuss it with your oncology team for personalised advice.

Medicine interactions: Capecitabine can interact with other medicines and supplements. It’s important to provide a full list of everything you take, including:

• prescription medicines
• over-the-counter pain relief and cold/flu products
• herbal remedies and supplements (for example, St John’s wort, which can affect drug metabolism)
• antacids and medicines for acid reflux

A pharmacist can check for likely interactions before you start and each time your medicines change.

8. Indications – when capecitabine is considered

In the UK, capecitabine is indicated for certain patients as determined by the oncology team and by national and local cancer pathways. Indications depend on the cancer type, stage, and treatment goals.

Typical clinical reasons for choosing capecitabine include:

• Adjuvant treatment after surgery to lower recurrence risk for some gastrointestinal cancers
• Systemic therapy for cancers that are locally advanced or metastatic, where control of disease and symptoms is important
• Combination regimens (for example with targeted therapies or other chemotherapy agents) where evidence supports benefit

If you’d like, share the cancer type and stage (without any personal identifiers), and a clinician-guided summary can help you understand typical UK pathways. For individual treatment suitability, your oncology team’s assessment is essential.

9. Dosing – what to expect

Capecitabine dosing is commonly based on body surface area (BSA) (a calculation using height and weight) and then expressed as: mg per square metre (mg/m²). Your oncology team sets the dose for your specific regimen.

Because dosing can change due to side effects, blood test results, or kidney function, the schedule may be adjusted during treatment.

Common dosing patterns (example framework):

• Oral dosing twice daily on treatment days
• Breaks or rest periods after a block of dosing
• Cycles repeated every few weeks depending on protocol

Dose modifications: Your team may reduce dose or pause treatment if you develop certain toxicities, such as:

• hand-foot syndrome (palmar-plantar erythrodysesthesia)
• significant diarrhoea
• low white blood cell or platelet counts
• severe mouth ulcers
• other serious side effects

How your team monitors you: You may have regular blood tests to check full blood count (FBC) and kidney/liver function. Monitoring is part of safe use and helps guide dose adjustments.

10. Safety profile – side effects and warning signs

Like all chemotherapy medicines, capecitabine can cause side effects. Many are manageable, but some require urgent medical attention. Your oncology team will discuss what to watch for and what actions to take.

Common side effects

• Diarrhoea (sometimes severe)
• Nausea and vomiting
• Loss of appetite
• Fatigue and weakness
• Stomach pain
• Mouth sores or inflammation (mucositis)
• Skin changes including dryness or rash
• Hand-foot syndrome (pain, redness, swelling, blistering, or peeling of skin on palms/soles)
• Changes in blood counts (for example, anaemia, low white cells)

Serious or urgent warning signs

Contact your cancer team urgently (or seek emergency help) if you experience:

• Signs of infection, such as fever (often defined clinically as a high temperature), chills, or feeling very unwell
• Severe diarrhoea or diarrhoea that doesn’t improve
• Persistent vomiting or inability to keep fluids down
• Severe mouth ulcers or difficulty drinking/chewing that leads to dehydration
• Severe hand-foot symptoms (ulcers, cracking, intense pain, or inability to perform normal activities)
• Allergic-type reactions (swelling of face/lips, wheezing, widespread rash)
• Breathlessness, chest pain, or neurological symptoms such as confusion

If you’re not sure whether a symptom is serious enough, it’s safer to contact your team.

Long-term considerations

Most effects resolve after treatment or improve with supportive care, but some people may experience lingering issues. Follow-up appointments and ongoing monitoring are important.

11. Practical use tips (day-to-day support)

Managing nausea and appetite changes

• Ask your oncology team about anti-sickness medicines (antiemetics) if you need them.
• Eat small, frequent meals rather than large ones.
• Choose bland foods if your stomach is sensitive.
• Keep hydrated, especially if diarrhoea occurs.

Reducing risk of hand-foot syndrome

• Keep hands and feet moisturised (use a recommended moisturiser regularly).
• Avoid friction and pressure: choose comfortable shoes and soft socks.
• Avoid hot water soaks and excessive heat on hands/feet.
• Inform your team early if you notice redness, tingling, or tenderness—early management can reduce severity.

Diarrhoea care

• Start hydration early (water, oral rehydration solutions if advised).
• Follow your clinic’s plan for anti-diarrhoeal medicines, including when to stop and when to seek help.
• Avoid foods that worsen symptoms (for example, very spicy foods, high-fat meals, or large amounts of caffeine) based on tolerance.

Oral care

• Use a gentle toothbrush and alcohol-free mouthwash if recommended.
• Report painful mouth sores early; treatments may reduce complications.

Blood test readiness

• Attend scheduled blood tests even if you feel well.
• Tell your team about symptoms between visits.

12. Alternative options (discuss with your oncology team)

Treatment choice depends on cancer type, stage, previous therapies, and your health profile. If capecitabine is not suitable or needs switching, options may include other chemotherapy regimens or different oral/intravenous fluoropyrimidines.

Possible alternatives (examples; not exhaustive) may include:

• 5-fluorouracil (5-FU) administered intravenously in various protocols
• Other oral fluoropyrimidines used in specific settings
• Different chemotherapy combinations depending on cancer type
• Targeted therapies or immunotherapies for selected tumours (based on biomarkers and clinical criteria)
• Supportive care approaches focusing on symptom control when appropriate

Your oncology team can explain what alternatives are relevant for your case and the expected differences in side effects, schedule, and monitoring.

13. UK market and legal context (how it is supplied)

In the United Kingdom, capecitabine is regulated as a prescription-only medicine. This means it is supplied under the care of a clinician and typically via NHS or private cancer services through licensed pharmacies.

Availability can depend on manufacturer supply, tablet strength, and local distribution. Online pharmacy services may show expected availability and delivery timeframes based on current stock and courier schedules.

Always check: the medicine strength, tablet count, expiry date, and packaging integrity when your order arrives.

14. Recent guidance and evolving practice (what to know)

Cancer treatment recommendations evolve as new evidence becomes available. In the UK, clinicians often align treatment decisions with:

• National cancer guidance and clinical pathways
• Local hospital protocols
• Safety updates and product-specific prescribing information
• Clinical trial results and consensus treatment recommendations

For capecitabine specifically, practice frequently focuses on:

• Early recognition of toxicities (especially diarrhoea and hand-foot syndrome)
• Prompt dose adjustments to reduce severe complications
• Individualised care for kidney function and other patient factors

If you are starting or restarting treatment, ask whether your regimen aligns with the latest protocol your team follows.

15. Delivery and availability (what online pharmacies in the UK may offer)

Delivery options vary by supplier. Many online pharmacies aim to provide:

• Clear stock status (in stock / low stock / on backorder)
• Tracking via courier services
• Delivery notifications by email or text
• Discrete packaging and secure handling
• Packaging checks upon dispatch and delivery

Storage at home: Keep your tablets as directed on the pack. Do not store in places with excessive heat or moisture. Keep medicines out of sight and reach of children.

If you need treatment continuity, consider ordering early to account for courier schedules and bank holidays.

16. FAQ – Frequently asked questions

Can I take capecitabine if I have kidney problems?

Kidney function affects how the body clears capecitabine metabolites. Your oncology team will assess kidney function using blood tests and may adjust the dose or schedule. Always discuss your latest kidney results with your clinician.

What should I do if I vomit soon after taking a dose?

Do not automatically take an extra dose unless instructed. Contact your oncology team or pharmacist for advice, as timing and your individual regimen matter.

How long does a capecitabine course last?

Treatment is typically given in cycles, and the overall duration depends on cancer type, stage, and response to therapy. Your clinician will explain the planned number of cycles.

Is capecitabine safe to take with other medicines?

Many medicines can be taken alongside chemotherapy, but interactions are possible. Always provide a full list to your pharmacist and oncology team, including herbal products and supplements.

Can I drive while taking capecitabine?

Some people experience fatigue, dizziness, or weakness. If you feel unwell or impaired, avoid driving and seek advice from your healthcare team. Follow UK guidance for driving during medication changes, and use caution.

What contraceptive precautions should I take?

Chemotherapy can affect rapidly dividing cells, including those involved in reproduction. Discuss contraception and pregnancy planning with your oncology team before starting treatment. Advice may differ for different situations and genders.

Does capecitabine affect fertility?

Chemotherapy may affect fertility in some people. Your team can discuss potential risks and fertility preservation options if relevant and available before treatment starts.

How should I handle missed doses?

Missed doses should be addressed according to your regimen’s instructions. In general, do not take extra doses to “catch up.” Contact your clinic or pharmacist for guidance specific to your schedule.

What can I do to manage tiredness?

Fatigue is common with chemotherapy. Prioritise rest, pace activities, maintain gentle movement if you’re able, and report severe or worsening fatigue to your team. Anaemia can contribute, so blood tests may be adjusted.

When should I contact my cancer team urgently?

If you have fever or signs of infection, severe diarrhoea, persistent vomiting, significant dehydration, severe mouth ulcers, or severe hand-foot syndrome, contact your team urgently for advice.

Summary

Capecitabine is an oral chemotherapy medicine converted in the body into an active form that helps stop cancer cells dividing. It is used in specific cancer types and settings across the UK, often delivered in cycles. Safe use depends on proper timing, consistent food-related instructions, monitoring of blood tests, and prompt management of side effects such as diarrhoea and hand-foot syndrome.

If you have any questions about how to take capecitabine, what side effects to watch for, or how it fits with your other medicines, speak with your pharmacist or oncology team.